Looking at glioma cells, and through in vitro and in vivo functional experiments, Bai et al. 36 showed that CDH18 acts as a tumor suppressor through the downstream gene target UQCRC2, and suggested targeting CDH18 in glioma treatmen. This evidence concerns the gene CDH18 and central nervous system cancer.